NEW YORK (GenomeWeb) – The National Institutes of Health announced that it has earmarked $2.6 million to fund groups that will participate in the National Human Genome Research Institute's Implementing Genomics in Practice (IGNITE) II: Pragmatic Clinical Trials Network initiative to conduct studies evaluating genomic medicine in routine clinical care.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.